In multiple tumor types, notably BRCA, HNSC, and glioma, HNRNPC emerged as the most broadly and abundantly expressed regulator across malignant and immune cells, consistent with its known role in m6A-mediated alternative splicing and RNA maturation. Here, HNRNPC is linked to neoplasm.